$EVH Cashflow Statement | Understand Stock

$EVH

$4.42 -$0.11 (2.43%) Close

$EVH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows Provided by Operating Activities
Net loss
Loss before preferred dividends and accretion of Series A Preferred Stock including excise tax
Adjustments to reconcile net loss to net cash and restricted cash provided by (used in) operating activities:
Change in fair value of contingent consideration
(Gain) loss on disposal of non-strategic assets
Loss on discontinued operations
(Gain) loss from equity method investees
Extinguishment of Series A Preferred Stock and other refinancing fees
Loss on option exercise
Depreciation and amortization expenses
Impairment of equity method investments
Stock-based compensation expense
Deferred tax benefit
Amortization of contract cost assets
Amortization of deferred financing costs
Interest from customer advance for regulatory capital requirements
Gain on transfer of membership
Change in tax receivable agreement liability
Loss on extinguishment/repayment of debt, net
Right-of-use asset impairment
Loss on lease termination
Change in tax receivables agreement liability
Right-of-use operating assets
Other current operating cash inflows (outflows), net
Changes in assets and liabilities, net of acquisitions:
Accounts receivable, net and contract assets
Prepaid expenses and other current and non-current assets
Contract cost assets
Accounts payable
Accrued liabilities
Operating lease liabilities
Accrued compensation and employee benefits
Deferred revenue
Reserve for claims and performance-based arrangements
Right-of-use operating assets
Other long-term liabilities

Net cash and restricted cash provided by operating activities
Cash Flows Used In Investing Activities
Cash paid for asset acquisitions and business combinations
Loan for implementation funding
Proceeds from transfer of membership and release of Passport escrow
Proceeds from disposal of non-strategic assets
Return of equity method investments
Customer advance for regulatory capital requirements
Investments in equity method investees
Impact to cash and cash equivalents and restricted cash from initial consolidation
Purchases of investments and contributions to equity method investees
Maturities and sales of investments
Investments in internal-use software and purchases of property and equipment
Other investing activities
Net cash and restricted cash used in investing activities

Cash Flows (Used In) Provided by Financing Activities
Changes in working capital balances related to claims processing
Amount received from escrow in asset acquisition
Proceeds from issuance of long term debt, net of offering costs
Issuance of warrant liability
Payment of contingent consideration
Proceeds from stock option exercises
Repayment and repurchase of 2021 Notes and financing fees
Proceeds from issuance of preferred stock, net of offering costs
Proceeds from issuance of long-term debt, net of offering costs
Distributions to Sponsors
Repayment of debt
Repurchase of common stock
Payment of preferred dividends
Taxes withheld and paid for vesting of equity awards
Net cash and restricted cash (used in) provided by financing activities

Effect of exchange rate on cash and cash equivalents and restricted cash
Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash as of beginning-of-period
Cash and cash equivalents and restricted cash as of end-of-period

Comments